US equities |
SPCX $160.06 ▲+8.30% MU $918.49 ▲+2.50% NVDA $221.75 ▲+2.44% TSLA $387.43 ▲+3.67% META $707.75 ▲+1.95% SNDK $1,392.56 ▲+1.99% GOOGL $334.54 ▼-1.68% AAPL $344.66 ▲+1.52%
FinancialContent

Latest News about Chikungunya

Recent news which mentions Chikungunya

Read Why Valneva's Stock Gained 7% Today
Tickers VALN
Tags Phase 3 Trial Health Care Trading Ideas
From Benzinga
Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents
Tickers VALN
Tags Chikungunya Health Care Phase 3 Trial
From Benzinga
Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
Tickers MRNA
Tags Market News Biotech Benzinga
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
Tickers VALN
Tags Biotech Market News Briefs
From Benzinga